Published in Arch Gynecol Obstet on September 09, 2011
Management of bleeding uterine arteriovenous malformation with bilateral uterine artery embolization. Yonsei Med J (2014) 0.94
Failed transarterial embolization of subserosal uterine arteriovenous malformation. Obstet Gynecol Sci (2013) 0.83
Uterine arteriovenous malformation caused by intrauterine instrumentation for laparoscopic surgery due to left tubal pregnancy. Obstet Gynecol Sci (2014) 0.79
Uterine arteriovenous malformation. BMJ Case Rep (2013) 0.78
Uterine Arteriovenous Malformation: Case Series and Literature Review. J Obstet Gynaecol India (2015) 0.75
Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease. Clin Case Rep (2015) 0.75
Acquired vascular malformation in ruptured caesarean section scar: a rare cause of life-threatening vaginal bleeding. BMJ Case Rep (2013) 0.75
Uterine arteriovenous vascular malformation masked by partial molar pregnancy: diagnostic challenge and subsequent embolic treatment. J Obstet Gynaecol India (2014) 0.75
A Systematic Review of Acquired Uterine Arteriovenous Malformations: Pathophysiology, Diagnosis, and Transcatheter Treatment. AJP Rep (2015) 0.75
Pregnancy after uterine arteriovenous malformation-case series and literature review. Australas J Ultrasound Med (2015) 0.75
Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline. Perm J (2013) 0.75
Hysteroscopic Management of Uterine Arteriovenous Malformation. JSLS (2017) 0.75
Acquired uterine arteriovenous fistula following dilatation and curettage: an uncommon cause of vaginal bleeding. Radiol Case Rep (2017) 0.75
A case with life-threatening uterine bleeding due to postmenopausal uterine arteriovenous malformation. BMC Womens Health (2015) 0.75
Diagnosis and management of life-threatening hypermenorrhagia caused by uterine arteriovenous malformation secondary to surgical termination of pregnancy: video evidence! BMJ Case Rep (2012) 0.75
Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. N Engl J Med (2012) 4.24
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. J Natl Cancer Inst (2013) 3.46
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. Lancet Oncol (2012) 2.72
Work-life balance of German gynecologists: a web-based survey on satisfaction with work and private life. Arch Gynecol Obstet (2013) 2.27
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol (2010) 1.71
Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology (2010) 1.70
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. J Clin Oncol (2009) 1.68
Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer (2007) 1.62
Characterization of a prenatally assessed de novo supernumerary minute ring chromosome 20 in a phenotypically normal male. Mol Cytogenet (2009) 1.43
Ovarian metastasis of a lymphoma presenting as primary ovarian cancer. Onkologie (2009) 1.40
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer. J Clin Oncol (2009) 1.31
Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res (2013) 1.27
Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett (2006) 1.21
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer. J Clin Oncol (2013) 1.20
Exacerbation of a maternal hiatus hernia in early pregnancy presenting with symptoms of hyperemesis gravidarum: case report and review of the literature. Arch Gynecol Obstet (2010) 1.18
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis (2005) 1.16
Breath isoprene--aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study. Clin Chem Lab Med (2008) 1.15
Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients. Breast (2010) 1.15
Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. Breast (2011) 1.14
Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. Cancer Biother Radiopharm (2004) 1.10
Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa. Am J Trop Med Hyg (2008) 1.10
Risk awareness and transparency. Dtsch Arztebl Int (2013) 1.10
Retziusscopy: a minimal invasive technique for the treatment of retropubic hematomas after TVT procedure. Eur J Obstet Gynecol Reprod Biol (2011) 1.05
[Short version of the guideline "Early Detection of Breast Cancer in Germany"]. Z Arztl Fortbild Qualitatssich (2004) 1.03
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics (2002) 1.03
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Cancer Gene Ther (2002) 1.03
Hemorrhagic complications associated with tension-free vaginal tape procedure. Obstet Gynecol (2004) 1.01
VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecol Oncol (2012) 0.99
Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol (2003) 0.99
Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). Clin Cancer Res (2004) 0.99
Role of SIRT1 in homologous recombination. DNA Repair (Amst) (2010) 0.99
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology (2002) 0.98
On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis (2006) 0.98
Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response. Oncol Rep (2004) 0.97
Unexpected results in the constitution of small supernumerary marker chromosomes. Eur J Med Genet (2012) 0.97
Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. Cancer Lett (2008) 0.96
Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. Eur J Cancer (2012) 0.96
Angiogenesis during primate placentation in health and disease. Reproduction (2003) 0.95
Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin Cancer Res (2003) 0.95
Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. Tumour Biol (2002) 0.93
Prediction of nodal involvement in breast cancer based on multiparametric protein analyses from preoperative core needle biopsies of the primary lesion. Clin Cancer Res (2008) 0.93
First Revision of the German S3 Guideline 'Diagnosis, Therapy, and Follow-Up of Breast Cancer' Breast Care (Basel) (2008) 0.93
Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care. BMC Cancer (2009) 0.93
Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer (2012) 0.92
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer). Breast Care (Basel) (2009) 0.92
CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans. Int J Mol Med (2007) 0.92
Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies. Cancer (2007) 0.92
Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology. Strahlenther Onkol (2011) 0.91
Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study. Onkologie (2010) 0.91
Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS. J Breath Res (2008) 0.90
Haemorrhage and nerve damage as complications of TVT-O procedure: case report and literature review. Arch Gynecol Obstet (2007) 0.90
Long-term results of the tension-free vaginal tape procedure in an unselected group: a 7-year follow-up study. Urology (2011) 0.90
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer. J Clin Oncol (2013) 0.89
Cryobanking of human ovarian tissue for anti-cancer treatment: comparison of vitrification and conventional freezing. Cryo Letters (2010) 0.89
Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patients. BMC Cancer (2013) 0.88
Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines. Cancer Lett (2002) 0.87
Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. Oncol Rep (2003) 0.87
Ovarian cancer: in search of better marker systems based on DNA repair defects. Int J Mol Sci (2013) 0.87
Re-vascularisation in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. Eur J Obstet Gynecol Reprod Biol (2009) 0.86
Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study. Onkologie (2010) 0.86
A novel breast cancer cell line initially established from pleural effusion: evolution towards a more aggressive phenotype. Int J Oncol (2007) 0.86
2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol (2008) 0.86
The power of DNA double-strand break (DSB) repair testing to predict breast cancer susceptibility. FASEB J (2012) 0.86
Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles. J Assist Reprod Genet (2012) 0.86
Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients. Ann Surg Oncol (2008) 0.86
Prenatal diagnosis of proximal partial trisomy 1q confirmed by comparative genomic hybridization array: molecular cytogenetic analysis, fetal pathology and review of the literature. Birth Defects Res A Clin Mol Teratol (2014) 0.85
Detection of congenital heart defects throughout pregnancy; impact of first trimester ultrasound screening for cardiac abnormalities. J Matern Fetal Neonatal Med (2012) 0.85
Partial breast irradiation after breast-conserving surgery. Strahlenther Onkol (2005) 0.85
Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer. Am J Obstet Gynecol (2003) 0.85
[Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study]. Z Evid Fortbild Qual Gesundhwes (2011) 0.85
Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience. Arch Gynecol Obstet (2010) 0.85
Immunotherapy and cancer vaccines in the management of breast cancer. Curr Pharm Des (2005) 0.84
Mechanical agitation during the in vitro culture of human pre-implantation embryos drastically increases the pregnancy rate. Clin Lab (2010) 0.84
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy. Breast Care (Basel) (2011) 0.84
Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits. Dtsch Arztebl Int (2014) 0.83
Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins. Fertil Steril (2013) 0.83
An interstitial 4q31.21q31.22 microdeletion associated with developmental delay: case report and literature review. Cytogenet Genome Res (2014) 0.83
Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. Neuro Endocrinol Lett (2003) 0.83
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV. Gynecol Oncol (2012) 0.83
Dual testing with QF-PCR and karyotype analysis for prenatal diagnosis of chromosomal abnormalities. Evaluation of 13,500 cases with consideration of using QF-PCR as a stand-alone test according to referral indications. Prenat Diagn (2012) 0.82
Pregnancy and delivery after tension-free vaginal tape (TVT) procedure: literature review and case report. Eur J Obstet Gynecol Reprod Biol (2010) 0.81
A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens. Int J Cancer (2008) 0.81
Common structural features characterize interstitial intrachromosomal Xp and 18q triplications. Am J Med Genet A (2011) 0.81
Voiding dysfunction after the tension-free vaginal tape procedure. Gynecol Obstet Invest (2011) 0.81
Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status. Cancer Gene Ther (2004) 0.81
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia. Hum Immunol (2011) 0.81
Complex Rearrangement Involving Three Chromosomes, Four Breakpoints and a 2.7-Mb Deletion in the 18q Segment Observed in a Girl with Mild Learning Difficulties. Cytogenet Genome Res (2015) 0.81
Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses. Genet Mol Biol (2012) 0.80
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients. BMC Cancer (2014) 0.80
Prenatal detection of TAR syndrome in a fetus with compound inheritance of an RBM8A SNP and a 334‑kb deletion: a case report. Mol Med Rep (2013) 0.80
Vitamin A and beta-carotene supply of women with gemini or short birth intervals: a pilot study. Eur J Nutr (2006) 0.79
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500. Cancer Gene Ther (2002) 0.79
Comparison of early onset breast cancer patients to older premenopausal breast cancer patients. Arch Gynecol Obstet (2010) 0.79
Sonographic antenatal diagnosis of congenital dacryocystoceles. J Clin Ultrasound (2012) 0.79
p53 autoantibodies can be indicative of the development of breast cancer relapse. Anticancer Res (2003) 0.79
Helicobacter pylori infection and the occurrence and severity of gastrointestinal symptoms during pregnancy. Am J Obstet Gynecol (2003) 0.78